Zhongchao to Effectuate 1-for-3 Share Consolidation
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 25 2026
0mins
Zhongchao will effectuate a 1-for-3 share consolidation of the company's ordinary shares of 24.8c par value each. Beginning with the opening of trading on June 29, the company's Class A ordinary shares will begin trading on a post-share consolidation basis on Nasdaq under the same symbol "ZCMD," but under a new CUSIP number of G9897X149. The objective of the share consolidation is to maintain its listing on the Nasdaq Capital Market. Upon the effectiveness of the share consolidation, every three Class A ordinary shares with a par value of 24.8c each will be consolidated into one Class A ordinary share with a par value of 74.4c each, and every three Class B ordinary shares with a par value of 24.8c each will be consolidated into one Class B ordinary share with a par value of 74.4c each. As a result of the consolidation, the company will have approximately 1,149,825 Class A ordinary shares and 6,721 Class B ordinary shares issued and outstanding.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ZCMD?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ZCMD
About ZCMD
Zhongchao Inc is a holding company primarily engaged in the provision of healthcare information, education, and training services to healthcare professionals and the public. The Company is primarily engaged in the provision of medical training and education services and assistance in patient-aid projects through MDMOOC online platform and offline formats. The MDMOOC online platform includes MDMOOC mobile application (App), MOOC Medical WeChat subscription account, and MDMOOC website. Under the MDMOOC brand, the Company provides various online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. The Company primarily operates its businesses in the domestic market.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Zhongchao Announces Share Consolidation Plan
- Share Consolidation Plan: Zhongchao has announced a 1-for-3 share consolidation aimed at maintaining its listing on the Nasdaq Capital Market, demonstrating the company's commitment to compliance with market regulations.
- Trading Schedule: The consolidated ordinary shares will begin trading on June 29, 2026, under the same symbol "ZCMD" on the Nasdaq Capital Market, ensuring consistency for investors.
- Capital Structure Changes: Prior to the consolidation, the company has 3.44 million Class A ordinary shares and 20,161 Class B ordinary shares outstanding, which will reduce to approximately 1.14 million Class A and 6,721 Class B shares post-consolidation, reflecting proactive adjustments in capital management.
- Market Impact Assessment: Through this consolidation, Zhongchao aims to enhance per-share value and boost investor confidence, thereby maintaining its position in a competitive market environment.
See More
Zhongchao Inc. Announces 1-for-31 Share Consolidation
- Share Consolidation Plan: Zhongchao Inc. will implement a 1-for-31 share consolidation effective June 8, 2026, to comply with Nasdaq Capital Market listing requirements, significantly increasing the par value of each share to $0.248.
- Shareholder Approval: The consolidation plan was approved by shareholders on February 10, 2026, and by the board of directors on March 31, 2026, indicating a stable and transparent governance structure within the company.
- Post-Consolidation Shares: After the consolidation, Zhongchao will have approximately 2,570,507 Class A ordinary shares and 20,161 Class B shares outstanding, a substantial reduction from 79,685,696 Class A and 624,972 Class B shares, which is expected to enhance per-share profitability.
- Market Performance: Currently, Zhongchao's stock is trading at $0.030, down 16.02% from the previous trading day, reflecting market caution regarding the company's future, with the consolidation plan potentially impacting investor confidence.
See More
Zhongchao Announces 1-for-31 Share Consolidation
- Share Consolidation Plan: Zhongchao has announced a 1-for-31 share consolidation of its ordinary shares, aiming to enhance the stock price per share by consolidating shares with a par value of $0.008 to meet Nasdaq Capital Market listing requirements.
- Trading Schedule: The consolidated ordinary shares will begin trading on Nasdaq under the same ticker symbol “ZCMD” starting June 8, ensuring that investors can smoothly transition to trading post-consolidation.
- Listing Maintenance Objective: The primary goal of this share consolidation is to maintain the company's listing on Nasdaq, reflecting its commitment to compliance and market recognition.
- Market Reaction Expectations: While the consolidation may have a positive short-term impact on the stock price, the company must continuously monitor market assessments of its long-term growth potential to ensure shareholder confidence and investor support.
See More
Zhongchao Inc. Announces Share Consolidation Plan
- Share Consolidation Details: Zhongchao Inc. will implement a 1-for-31 share consolidation on June 8, 2026, where every 31 Class A ordinary shares will convert into one share, aimed at maintaining its Nasdaq listing and enhancing market confidence.
- Capital Structure Changes: Prior to the consolidation, the company has 79,685,696 Class A and 624,972 Class B ordinary shares, with an expected post-consolidation total of approximately 2,570,507 Class A and 20,161 Class B shares, indicating efforts to optimize capital structure.
- Shareholder Impact: The consolidation will uniformly affect all shareholders, with adjustments for fractional shares, but will not alter any shareholder's percentage interest in the company's total shares, ensuring stability in shareholder equity.
- Management Approval: The consolidation plan was approved by shareholders on February 10, 2026, and by the board of directors on March 31, 2026, reflecting transparency in corporate governance and compliance in decision-making.
See More
Zhongchao Inc. Prices Public Offering at $0.54 per Unit
- Offering Size: Zhongchao Inc. (ZCMD) has priced its best-efforts public offering at $0.54 per unit for a total of 9.26 million units, expecting gross proceeds of approximately $5 million, which highlights the company's ability to raise capital in the market.
- Subscription Details: Each unit consists of one Class A ordinary share and a warrant with an exercise price of $0.594 per share, expiring six months post-issuance, indicating the company's appeal to investors and potential returns.
- Market Performance: ZCMD's stock has traded between $0.08 and $12.18 over the past year, currently at $0.09, down 42.28% from Friday's close of $0.17, reflecting market caution regarding its future performance.
- Underwriter Role: Univest Securities, LLC serves as the sole placement agent for this offering, underscoring its significance and expertise in facilitating the company's capital-raising efforts.
See More
Biotech Stocks Show Significant Pre-Market Activity
- Significant Pre-Market Gains: Genenta Science S.p.A. (GNTA) surged 135% to $2.42 in pre-market trading, indicating strong market optimism about its potential breakthroughs, which may attract more investor interest.
- Healthy Choice Performance: Healthy Choice Wellness Corp. (HCWC) rose 30% to $0.43, reflecting increased market demand for its products, potentially boosting future sales and market share for the company.
- Pre-Market Decliners: Zhongchao Inc. (ZCMD) fell 34% to $0.11 in pre-market trading, signaling market concerns about its outlook, which may lead investors to reassess their investment strategies.
- Overall Market Sentiment: The overall pre-market activity in the biotech sector shows significant volatility, as investors seek potential breakout opportunities, which could influence trading strategies in the market.
See More
Zhongchao Announces Share Consolidation Plan
- Share Consolidation Plan: Zhongchao has announced a 1-for-3 share consolidation aimed at maintaining its listing on the Nasdaq Capital Market, demonstrating the company's commitment to compliance with market regulations.
- Trading Schedule: The consolidated ordinary shares will begin trading on June 29, 2026, under the same symbol "ZCMD" on the Nasdaq Capital Market, ensuring consistency for investors.
- Capital Structure Changes: Prior to the consolidation, the company has 3.44 million Class A ordinary shares and 20,161 Class B ordinary shares outstanding, which will reduce to approximately 1.14 million Class A and 6,721 Class B shares post-consolidation, reflecting proactive adjustments in capital management.
- Market Impact Assessment: Through this consolidation, Zhongchao aims to enhance per-share value and boost investor confidence, thereby maintaining its position in a competitive market environment.
See More
Zhongchao Inc. Announces 1-for-31 Share Consolidation
- Share Consolidation Plan: Zhongchao Inc. will implement a 1-for-31 share consolidation effective June 8, 2026, to comply with Nasdaq Capital Market listing requirements, significantly increasing the par value of each share to $0.248.
- Shareholder Approval: The consolidation plan was approved by shareholders on February 10, 2026, and by the board of directors on March 31, 2026, indicating a stable and transparent governance structure within the company.
- Post-Consolidation Shares: After the consolidation, Zhongchao will have approximately 2,570,507 Class A ordinary shares and 20,161 Class B shares outstanding, a substantial reduction from 79,685,696 Class A and 624,972 Class B shares, which is expected to enhance per-share profitability.
- Market Performance: Currently, Zhongchao's stock is trading at $0.030, down 16.02% from the previous trading day, reflecting market caution regarding the company's future, with the consolidation plan potentially impacting investor confidence.
See More
Zhongchao Announces 1-for-31 Share Consolidation
- Share Consolidation Plan: Zhongchao has announced a 1-for-31 share consolidation of its ordinary shares, aiming to enhance the stock price per share by consolidating shares with a par value of $0.008 to meet Nasdaq Capital Market listing requirements.
- Trading Schedule: The consolidated ordinary shares will begin trading on Nasdaq under the same ticker symbol “ZCMD” starting June 8, ensuring that investors can smoothly transition to trading post-consolidation.
- Listing Maintenance Objective: The primary goal of this share consolidation is to maintain the company's listing on Nasdaq, reflecting its commitment to compliance and market recognition.
- Market Reaction Expectations: While the consolidation may have a positive short-term impact on the stock price, the company must continuously monitor market assessments of its long-term growth potential to ensure shareholder confidence and investor support.
See More
Zhongchao Inc. Announces Share Consolidation Plan
- Share Consolidation Details: Zhongchao Inc. will implement a 1-for-31 share consolidation on June 8, 2026, where every 31 Class A ordinary shares will convert into one share, aimed at maintaining its Nasdaq listing and enhancing market confidence.
- Capital Structure Changes: Prior to the consolidation, the company has 79,685,696 Class A and 624,972 Class B ordinary shares, with an expected post-consolidation total of approximately 2,570,507 Class A and 20,161 Class B shares, indicating efforts to optimize capital structure.
- Shareholder Impact: The consolidation will uniformly affect all shareholders, with adjustments for fractional shares, but will not alter any shareholder's percentage interest in the company's total shares, ensuring stability in shareholder equity.
- Management Approval: The consolidation plan was approved by shareholders on February 10, 2026, and by the board of directors on March 31, 2026, reflecting transparency in corporate governance and compliance in decision-making.
See More
Zhongchao Inc. Prices Public Offering at $0.54 per Unit
- Offering Size: Zhongchao Inc. (ZCMD) has priced its best-efforts public offering at $0.54 per unit for a total of 9.26 million units, expecting gross proceeds of approximately $5 million, which highlights the company's ability to raise capital in the market.
- Subscription Details: Each unit consists of one Class A ordinary share and a warrant with an exercise price of $0.594 per share, expiring six months post-issuance, indicating the company's appeal to investors and potential returns.
- Market Performance: ZCMD's stock has traded between $0.08 and $12.18 over the past year, currently at $0.09, down 42.28% from Friday's close of $0.17, reflecting market caution regarding its future performance.
- Underwriter Role: Univest Securities, LLC serves as the sole placement agent for this offering, underscoring its significance and expertise in facilitating the company's capital-raising efforts.
See More
Biotech Stocks Show Significant Pre-Market Activity
- Significant Pre-Market Gains: Genenta Science S.p.A. (GNTA) surged 135% to $2.42 in pre-market trading, indicating strong market optimism about its potential breakthroughs, which may attract more investor interest.
- Healthy Choice Performance: Healthy Choice Wellness Corp. (HCWC) rose 30% to $0.43, reflecting increased market demand for its products, potentially boosting future sales and market share for the company.
- Pre-Market Decliners: Zhongchao Inc. (ZCMD) fell 34% to $0.11 in pre-market trading, signaling market concerns about its outlook, which may lead investors to reassess their investment strategies.
- Overall Market Sentiment: The overall pre-market activity in the biotech sector shows significant volatility, as investors seek potential breakout opportunities, which could influence trading strategies in the market.
See More
